Sana Biotechnology (SANA)
(Delayed Data from NSDQ)
$5.41 USD
-0.09 (-1.64%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $5.42 +0.01 (0.18%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Sana Biotechnology (SANA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$12.50 | $15.00 | $7.00 | 127.27% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Sana Biotechnology comes to $12.50. The forecasts range from a low of $7.00 to a high of $15.00. The average price target represents an increase of 127.27% from the last closing price of $5.50.
Analyst Price Targets (6 )
Broker Rating
Sana Biotechnology currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.75 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, five are Strong Buy, representing 62.5% of all recommendations. A month ago, Strong Buy represented 62.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/9/2024 | Cowen & Co. | Marc Frahm | Hold | Hold |
8/9/2024 | H.C. Wainwright & Co. | Emily Bodnar | Strong Buy | Strong Buy |
6/1/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/1/2024 | JMP Securities | Reni Benjamin | Strong Buy | Strong Buy |
10/16/2023 | Goldman Sachs | Salveen Richter | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.75 |
ABR (Last week) | 1.75 |
# of Recs in ABR | 8 |
Average Target Price | $12.50 |
LT Growth Rate | 11.20% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 84 of 253 |
Current Quarter EPS Est: | -0.27 |
SANA FAQs
Sana Biotechnology, Inc. (SANA) currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Sana Biotechnology, Inc. (SANA) is $12.50. The current on short-term price targets is based on 3 reports.
The forecasts for Sana Biotechnology, Inc. (SANA) range from a low of $7 to a high of $15. The average price target represents a increase of $131.05 from the last closing price of $5.41.
The current UPSIDE for Sana Biotechnology, Inc. (SANA) is 131.05%
Based on short-term price targets offered by six analysts, the average price target for Sana Biotechnology comes to $12.50. The forecasts range from a low of $7.00 to a high of $15.00. The average price target represents an increase of 127.27% from the last closing price of $5.50.